These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 34501647)

  • 1. Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity.
    Guzmán-Martínez O; Guardado K; Varela-Cardoso M; Trujillo-Rivera A; Gómez-Ñañez I; Ortiz-León MC; Espinosa R; Ramos C; Pérez-Carreón JI; López-Guerrero DV; Sampieri CL; Alanís-García AB; Rojas-Durán F; Zenteno-Cuevas R; Gutiérrez M; Montero H
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
    Asamoah-Boaheng M; Grunau B; Karim ME; Jassem AN; Bolster J; Marquez AC; Scheuermeyer FX; Goldfarb DM
    Front Immunol; 2022; 13():954093. PubMed ID: 36159791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
    Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
    Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
    Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
    BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
    Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
    Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities.
    Imai K; Matsuoka M; Tabata S; Kitagawa Y; Nagura-Ikeda M; Kubota K; Fukada A; Takada T; Sato M; Noguchi S; Takeuchi S; Arakawa N; Miyoshi K; Saito Y; Maeda T
    Int J Infect Dis; 2021 Oct; 111():68-75. PubMed ID: 34407480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
    Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
    J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
    Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H
    Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
    Woudenberg T; Pelleau S; Anna F; Attia M; Donnadieu F; Gravet A; Lohmann C; Seraphin H; Guiheneuf R; Delamare C; Stefic K; Marlet J; Brochot E; Castelain S; Augereau O; Sibilia J; Dubos F; Meddour D; Guen CG; Coste-Burel M; Imbert-Marcille BM; Chauvire-Drouard A; Schweitzer C; Gatin A; Lomazzi S; Joulié A; Haas H; Cantais A; Bertholon F; Chinazzo-Vigouroux MF; Abdallah MS; Arowas L; Charneau P; Hoen B; Demeret C; Werf SV; Fontanet A; White M
    EBioMedicine; 2021 Aug; 70():103495. PubMed ID: 34304047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.
    Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination.
    Hu C; Wang Z; Ren L; Hao Y; Zhu M; Jiang H; Wang S; Li D; Shao Y
    Front Cell Infect Microbiol; 2022; 12():978440. PubMed ID: 36118022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dominance of human coronavirus OC43 and NL63 infections in infants.
    Dijkman R; Jebbink MF; Gaunt E; Rossen JW; Templeton KE; Kuijpers TW; van der Hoek L
    J Clin Virol; 2012 Feb; 53(2):135-9. PubMed ID: 22188723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.
    Adami FL; de Castro MV; Almeida BDS; Daher IP; Yamamoto MM; Souza Santos K; Zatz M; Naslavsky MS; Rosa DS; Cunha-Neto E; de Oliveira VL; Kalil J; Boscardin SB
    Front Immunol; 2024; 15():1396603. PubMed ID: 38846944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral response to SARS-CoV-2 and seasonal coronaviruses in COVID-19 patients.
    Adams O; Andrée M; Rabl D; Ostermann PN; Schaal H; Lehnert E; Ackerstaff S; Müller L; Fischer JC
    J Med Virol; 2022 Mar; 94(3):1096-1103. PubMed ID: 34716706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
    Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
    Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective presence of antibodies against common human coronaviruses in immunoglobulin medicinal products.
    Díez JM; Romero C; Gajardo R
    Int J Infect Dis; 2022 Mar; 116():68-73. PubMed ID: 34929360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
    Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
    PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines.
    Joseph JO; Ylade M; Daag JV; Aogo R; Crisostomo MV; Mpingabo P; Premkumar L; Deen J; Katzelnick LC
    BMC Infect Dis; 2024 Sep; 24(1):1042. PubMed ID: 39333882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.